Qing Hai Zhang

Qing Hai Zhang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2025 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
LZLijia Zhang
Lijia Zhang
RXRongjiang Xu
Rongjiang Xu
HHHao Huang
Hao Huang
JYJuan Yang
Juan Yang
CYChangyin Yu
Changyin Yu
ZXZucai Xu
Zucai Xu
Epilepsy is a prevalent chronic neurological disorder, affecting approximately 70 million individuals globally, with its pathogenesis primarily attributed to recurrent seizures caused by abnormal neuronal discharges in the brain. Recent research has increasingly recognized the critical role of neuroinflammation in the central nervous system in the onset and progression of epilepsy. Furthermore, the gut-brain axis, a crucial link between gut microbiota and the central nervous system, facilitates communication through intricate pathways involving neural, immune, and endocrine mechanisms, and its involvement in epilepsy pathology is gaining significant attention. This review focuses on recent advances in neuroimmune interactions within the gut-brain axis in epilepsy. It explores the roles of inflammatory factors (e.g., IL-1β, IL-6, TNF-α) and immune cells (e.g., microglia, macrophages, neutrophils) in epileptic pathophysiology, and systematically reviews relevant experimental and clinical studies. The article begins by providing an overview of the fundamental interactions between gut microbiota and the host immune system, before discussing how gut-derived immune signals influence the central nervous system via the gut-brain axis. The pathogenic mechanisms of key pro-inflammatory factors in epileptogenesis are then examined, including how IL-1β promotes neuronal hyperexcitability, how IL-6 mediates neuroinflammation, and how TNF-α disrupts the balance between neuronal excitation and inhibition. Additionally, the article highlights the significant role of inflammatory cells in the central nervous system, particularly the activation of microglia and the infiltration of peripheral immune cells in epilepsy development. In conclusion, further investigation into the mechanisms of neuroimmune interactions in the gut-brain axis may lead to the identification of novel biomarkers and therapeutic targets for epileptogenesis, offering new insights and directions for the treatment of refractory epilepsy.

24 May 2024 in Medicine
Verified
Journal Article
Open access
MZmanmin zhu
manmin zhu
CYChangyin Yu
Changyin Yu
ZXZucai Xu
Zucai Xu
QZQing Hai Zhang
Qing Hai Zhang
HHhao huang
hao huang
Rationale: Subacute combined degeneration of the spinal cord is a degenerative disease of the central and peripheral nervous systems caused by vitamin B12 deficiency, mainly involving the spinal cord posterior, lateral, and peripheral nerves, but rarely involving the cerebellum. Patient concerns: A 41-year-old woman presented with a 2-year history of walking unsteadily. Her hematologic examination revealed megaloblastic anemia and vitamin B12 deficiency. Electromyography showed multiple peripheral nerve damage (sensory fibers and motor fibers were involved). Imaging examination showed long T2 signal in the cervical, thoracic and lumbar spinal cord and cerebellum. Gastroscopy revealed autoimmune gastritis. Diagnoses: Subacute combined degeneration of the spinal cord. Interventions: By supplementing with vitamin B12. Outcomes: The patient’s symptoms of limb weakness, diet, and consciousness were improved, and the muscle strength of both lower limbs recovered to grade IV. Lessons: The symptomatic people should seek medical treatment in time to avoid further deterioration of the disease. When esophagogastroduodenoscopy is performed as part of routine physical examination in asymptomatic people, it should be checked for the presence of autoimmune gastritis. Early diagnosis can prevent irreversible neuropathy.

28 December 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
ZZZunlin Zhou
Zunlin Zhou
XWXiujuan Wang
Xiujuan Wang
JYJuan Yang
Juan Yang
JQJiyao Qin
Jiyao Qin
BFBidan Feng
Bidan Feng
QZQing Hai Zhang
Qing Hai Zhang
Background: Epilepsy is a prevalent chronic neurological disorder characterized by its complex pathophysiology, with microglial phagocytosis being crucial for synaptic remodeling and epileptogenesis. Transglutaminase‐2 (TGM2) holds a critical role in regulating microglial function and cognitive synaptic plasticity; however, the precise mechanisms by which TGM2 influences synaptic pruning and epileptogenesis remain unclear. Aim: This study aims to investigate the role of TGM2 in seizure susceptibility and its regulatory effects on microglial‐mediated synaptic phagocytosis in a chronic epilepsy model. Accordingly, the following objectives were set: elucidate the fluorescent localization and protein expression characteristics of TGM2 in normal and epileptic brain tissues; analyze the impact of TGM2 on epileptic behavioral phenotypes; and investigate the molecular mechanisms underlying its regulation of microglial activation and synaptic phagocytic function using an epileptic mouse model. Methods: In vivo experiments were performed using a kainic acid (KA)–induced chronic epilepsy mouse model established via intrahippocampal injection. Western blot and immunofluorescence analyses were employed to examine TGM2 expression and localization in the hippocampus of KA‐treated mice. Adeno‐associated virus vectors were used to achieve TGM2 overexpression or knockdown in the hippocampus, after which video‐monitored behavioral assays and in vivo field potential recordings were used to evaluate seizure latency, frequency, and severity. Golgi–Cox staining, western blotting, and immunofluorescence were used to assess dendritic spine density in the hippocampal CA1 region, microglial polarization (M1/M2 phenotypes), and phagocytic activity. In vitro studies in BV2 microglia explored the molecular mechanisms of action of TGM2 using ubiquitination assays targeting ATP‐binding cassette transporter A1 (ABCA1). Results: TGM2 expression was significantly upregulated in the hippocampus of KA‐induced epileptic mice, which prolonged the latency period to spontaneous recurrent seizures (SRS) and reduced SRS frequency. In contrast, TGM2 knockdown exacerbated seizure severity, which was characterized by a shortened latency period and increased SRS frequency. Golgi–Cox staining revealed that TGM2 overexpression decreased dendritic spine density in the CA1 region, whereas TGM2 knockdown had the opposite effect, indicating a role in synaptic remodeling. Functional analyses showed that TGM2 promoted microglial polarization toward an anti‐inflammatory M2 phenotype, enhanced phagocytic activity, and upregulated the components of the complement system as well as the phagocytosis‐related proteins. Conversely, TGM2 deficiency promoted the pro‐inflammatory M1 phenotype, reduced phagocytic capacity, and downregulated the components of the complement system and the phagocytosis‐related proteins. Mechanistically, TGM2 overexpression increased ABCA1 protein stability by inhibiting its ubiquitination, whereas TGM2 knockdown promoted ABCA1 ubiquitination and degradation. Immunofluorescence analysis revealed enhanced colocalization of TGM2 within the microglia. Conclusion: This study revealed that TGM2 suppresses epileptogenesis by enhancing microglial synaptic phagocytosis through the inhibition of ABCA1 ubiquitination, thereby regulating synaptic remodeling in the hippocampus. These findings establish a critical molecular link between TGM2‐mediated microglial function and epileptogenesis, providing novel insights into therapeutic strategies targeting neuroinflammation and synaptic plasticity in epilepsy.

28 October 2022 in Medicine
Verified
Journal Article
Open access
ZLZhong Luo
Zhong Luo
LZLinhai Zhang
Linhai Zhang
JYJuan Yang
Juan Yang
QZQing Hai Zhang
Qing Hai Zhang
TLTao Liang
Tao Liang
Rationale: Hereditary motor-sensory peripheral neuropathy, or Charot-Marie-Tooth (CMT) Charcot-Marie-Tooth disease is an inherited peripheral neuropathy characterized by progressive limb weakness and muscle atrophy. As the disease progresses, sensory and autonomic involvement may occur. We report a case of CMT associated with SOD1 gene mutation, in order to provide new ideas for clinical disease diagnosis. Patient concerns: A 50-years-old female patient was admitted to the hospital with “progressive weakness of the right lower extremity for 5 years, aggravating, and weakness of the left lower extremity for 4 months”. Diagnosis: The patient was diagnosed CMT. Intervention: Nerve nutrition and rehabilitation therapy were given, but the patient’s condition still did not improve significantly. Outcomes: The improvement of symptoms was not obvious. Lessons: The clinical manifestations and electromyography results of this patient are consistent with the characteristics of CMT. The peripheral nerve-related hereditary gene test found mutation in SOD1. It is possible that this mutation is linked to CMT. The disease is a neurodegenerative disease, that may be slowed by physical therapy and rehabilitation, but could not be healed.

11 January 2023 in Ibrain
Verified
Journal Article
Open access
XYXiaoyan Yang
Xiaoyan Yang
WLWenbo Lv
Wenbo Lv
YYYong Yang
Yong Yang
JYJuan Yang
Juan Yang
QZQing Hai Zhang
Qing Hai Zhang
ZXZucai Xu
Zucai Xu
It was found the expression of progesterone receptor membrane component 2 (PGRMC2) in the histone of epileptic mice was lower than that of normal mice. In this study, we found by the immunofluorescence technique, PGRMC2 was expressed in both astrocytes and neurons of the mouse hippocampus. In addition, the seizure latency and seizure grade of mice in each group were observed after stereotactic injection of the PGRMC2 knockdown virus, PGRMC2 overexpression lentivirus, and related null virus into the hippocampus of mice. It was found that the seizure latency of mice in the PTZ + siPGRMC2 group was prolonged compared with the null virus group. The seizure latency was shortened in the PTZ + PGRMC2 group. The number of grade IV and above seizures in the PTZ + siPGRMC2 group was significantly reduced, while the number of grade IV and above seizures in the PTZ + PGRMC2 group was significantly increased. It was found that the nerve cells in the PTZ + siPGRMC2 group were still intact. In the PTZ + PGRMC2 group, the neural cells were damaged, the intercellular space was widened, and the number of cells was reduced. These findings support that PGRMC2 may be involved in epileptic seizures.

1 October 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
LZLiangxue Zhang
Liangxue Zhang
JYJiaxin Yang
Jiaxin Yang
YYYuhua Yang
Yuhua Yang
MYMin Yang
Min Yang
JYJuan Yang
Juan Yang
ZXZucai Xu
Zucai Xu
Nearly 16% of the world’s population is affected by neurological disorders, including neurodegenerative and neuroimmune diseases caused by acute or chronic inflammation. Inflammatory processes in the central nervous system can exacerbate these diseases by causing neuronal damage and apoptosis. Traditional Chinese medicines have become an important area of research in anti-neuroinflammation and neuroprotection owing to their multi-target effects and favorable safety profiles. In this paper, we review the molecular mechanisms by which bioactive compounds of herbal origin inhibit neuroinflammation and improve disease progression through the modulation of inflammatory factors (including TLR4/MyD88/NF-κB, NLRP3 inflammasomes, and Janus kinase-STAT signaling), epigenetic modifications, cell-type-specific modulation (microglia M1/M2 polarization and astrocyte A1/A2 transformation), and gut-brain axis interactions. These bioactive compounds are mainly classified into those with well-defined chemical structures (such as baicalein, baicalin, berberine, and ginsenoside Rg1), plant extracts (such as tonifying Yang Huiwu Tang, Tongxinluo capsule, Shu Xuning injection, and Xingxiong injection), and preparations based on special mechanisms of action or technical means (such as Hedysari polysaccharides [RHP] and microglial cell exosome carrier berberine and palmatine [Exos-Ber/Pal]). We found that these compounds can improve cognitive and motor dysfunction by inhibiting neuroinflammation while exerting neuronal protection, but their low bioavailability, mechanistic complexity, and lack of clinical translational evidence remain challenges. In the future, a combination of multi-omics techniques, rigorously designed clinical trials, and interdisciplinary strategies will be required to promote the precise application of herbal medicines in neuroinflammation-related diseases.